NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1861640344 M.D., PH.D.
Verify on CMS → Andrei Marconescu, M.D., PH.D.
Hematology & Oncology Physician in Houston, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 253 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.1/100
▲ 11 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Andrei Marconescu, M.D., PH.D. reported a CMS MIPS final score of 94.1/100 - above the 83.5 national average - and filed 1,116 Medicare Part D claims in 2024.
- 94.1/100
- MIPS score · +11 vs avg
- 1K
- Part D claims, 2024
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Andrei Marconescu, M.D., PH.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1861640344), first enumerated 09/08/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,116 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 94.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Andrei Marconescu, M.D., PH.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1861640344 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1861640344
- ENUM-MID 2008
- TAX-MID 12K Hematology &
- MIPS-ELITE 94.1/100
- RX-MID 1,116
- BOOK-LIGHT 637 in Texas
- PHOTO-FINISH Stefan Gorsch · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Marconescu · thi…
Marconescu · this provider
94.1 MIPS pts
- Mahmood Rasheed …
Mahmood Rasheed
94.1 MIPS pts
- Stefan Gorsch · …
Stefan Gorsch
94.1 MIPS pts
- Kirsten Hinson ·…
Kirsten Hinson
94.1 MIPS pts
- Emily Jenkins · …
Emily Jenkins
94.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Andrei Marconescu, M.D., PH.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
94 ≥ 73rd percentile 73% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Andrei Marconescu, M.D., PH.D. sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Andrei Marconescu, M.D., PH.D. writes more Part D claims than 69% of them and scores higher on MIPS quality than 71% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Andrei Marconescu, M.D., PH.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Andrei Marconescu, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Andrei Marconescu, M.D., PH.D.?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,116 26% vs specialty avg
MIPS final score
94.1/100 10.6 pts vs avg
Specialty distribution in Texas
How Hematology & Oncology Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Andrei Marconescu, M.D., PH.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 94.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1861640344 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D., PH.D. |
| Gender | Male |
| NPI Issued | 09/08/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
94.0743
Final Score
Measured-score avg: 83.5
86.4483
Quality
94
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Andrei Marconescu, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Kauai Medical Clinic
Lihue, HI
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Andrei Marconescu, M.D., PH.D.. To verify Andrei Marconescu, M.D., PH.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Andrei Marconescu, M.D., PH.D. - brand share 19.0%
Hematology & Oncology Physician average
19% brand-name claims vs 81% generic, on 1,116 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,116
Total Claims
$3.4M
Total Drug Cost
253
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,552.1
- Total Day Supply
- 40,571
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $2.4M
- Generic Drug Cost
- $924K
- Opioid Claims
- 46 (4.1% rate)
- Antibiotic Claims
- 19
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 2.31
- Gender Split
- 48% female / 52% male
- Age Distribution
- <65: 18, 65-74: 108, 75-84: 101, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Andrei Marconescu, M.D., PH.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Prednisone
Prednisone
108 claims
- Abiraterone Acetate
Abiraterone Acetate
107 claims
- Ondansetron Hcl
Ondansetron Hcl
68 claims
- Dexamethasone
Dexamethasone
49 claims
- Lenalidomide
Lenalidomide
47 claims
- Anastrozole 43
Anastrozole
43 claims
- Letrozole 43
Letrozole
43 claims
- Eliquis 36
Eliquis
36 claims
| Drug | Claims |
|---|---|
| Prednisone | 108 |
| Abiraterone Acetate | 107 |
| Ondansetron Hcl | 68 |
| Dexamethasone | 49 |
| Lenalidomide | 47 |
| Anastrozole | 43 |
| Letrozole | 43 |
| Eliquis Apixaban | 36 |
| Potassium Chloride | 34 |
| Valacyclovir Valacyclovir Hcl | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Andrei Marconescu, M.D., PH.D. fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Andrei Marconescu, M.D., PH.D.'s 1,116 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Marconescu, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (94.1 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Marconescu.
One of 637 Hematology & Oncology Physician providers enrolled in Texas, 5 are shown here.
Dr. Elham Abbasi-Hafshejani
M.D.
The Woodlands, TX
Dr. Muhammad Abid
M.D.
Lubbock, TX
Dr. Ambrose Aboud
MD
El Paso, TX
Dr. Joel Abramowitz
M.D., PHD
Houston, TX
Dr. John Adams
DO
Arlington, TX
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Andrei Marconescu, M.D., PH.D.'s specialty? ▼
Andrei Marconescu, M.D., PH.D. specializes in Hematology & Oncology Physician and practices in Houston, Texas. Credentials: M.D., PH.D..
How much does Andrei Marconescu, M.D., PH.D. prescribe under Medicare Part D? ▼
In 2024, Andrei Marconescu, M.D., PH.D. wrote 1,116 Medicare Part D claims totaling $3.4M in drug costs for 253 beneficiaries.
What is Andrei Marconescu, M.D., PH.D.'s Medicare quality score? ▼
Andrei Marconescu, M.D., PH.D. has a CMS MIPS Final Score of 94.1/100 (Quality: 86.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Andrei Marconescu, M.D., PH.D. located? ▼
Andrei Marconescu, M.D., PH.D. is located at 1 BAYLOR PLZ, Houston, TX, 77030. Phone: (713) 798-0144.
What is Andrei Marconescu, M.D., PH.D.'s NPI number? ▼
Andrei Marconescu, M.D., PH.D.'s National Provider Identifier (NPI) is 1861640344, issued on 09/08/2008.
Does Andrei Marconescu, M.D., PH.D. prescribe more brand-name or generic drugs? ▼
Andrei Marconescu, M.D., PH.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $2.4M in brand drug costs.
Does Andrei Marconescu, M.D., PH.D. prescribe opioids? ▼
Yes, Andrei Marconescu, M.D., PH.D. had 46 opioid claims in 2024 with an opioid prescribing rate of 4.1%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Andrei Marconescu, M.D., PH.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Andrei Marconescu, M.D., PH.D.'s most frequently prescribed drugs include Prednisone, Abiraterone Acetate, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Andrei Marconescu, M.D., PH.D. accept Medicare? ▼
Andrei Marconescu, M.D., PH.D. appears in CMS Medicare data with 1,116 Part D claims and 253 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Andrei Marconescu, M.D., PH.D.'s credentials? ▼
Andrei Marconescu, M.D., PH.D.'s NPI is 1861640344 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.